Related references
Note: Only part of the references are listed.Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M1Muscarinic Acetylcholine Receptor
Manuela Jorg et al.
CHEMMEDCHEM (2021)
Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators
Samantha E. Yohn et al.
MOLECULAR PSYCHIATRY (2020)
Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes
Kayla J. Temple et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype
Kayla J. Temple et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs
Sophie J. Bradley et al.
NATURE CHEMICAL BIOLOGY (2020)
Efficacy and Safety of Xanomeline, a M1/M4 Receptor Preferencing Agonist, Plus Trospium, a Peripheral Muscarinic Antagonist, in Schizophrenia: Phase 2 Clinical Trial Results
Stephen Brannan et al.
BIOLOGICAL PSYCHIATRY (2020)
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M1 Positive Allosteric Modulators
Julie L. Engers et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Discovery, Optimization, and Biological Characterization of 2,3,6-Trisubstituted Pyridine-Containing M4 Positive Allosteric Modulators
Jeffrey W. Schubert et al.
CHEMMEDCHEM (2019)
The high efficacy of muscarinic M4 receptor in D1 medium spiny neurons reverses striatal hyperdopaminergia
Anu G. Nair et al.
NEUROPHARMACOLOGY (2019)
The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
Sachchida Nand Rai et al.
NEUROTOXICITY RESEARCH (2019)
VU6005806/AZN-00016130, an advanced M4 positive allosteric modulator (PAM) profiled as a potential preclinical development candidate
Darren W. Engers et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
14-3-3 signal adaptor and scaffold proteins mediate GPCR trafficking
Luwa Yuan et al.
SCIENTIFIC REPORTS (2019)
Discovery of a novel 3,4-dimethylcinnoline carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping
Kayla J. Temple et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia
Shaun Hopper et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M1 Receptor, and Xanomeline, an Agonist of Muscarinic M1/M4 Receptor, in Rodents
Takao Mandai et al.
NEUROSCIENCE (2019)
6-Phenylpyrimidin-4-ones as Positive Allosteric Modulators at the M1 mAChR: The Determinants of Allosteric Activity
Manuela Jorg et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands
Michael S. Poslusney et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Gq-Coupled Muscarinic Receptor Enhancement of KCNQ2/3 Channels and Activation of TRPC Channels in Multimodal Control of Excitability in Dentate Gyrus Granule Cells
Chase M. Carver et al.
JOURNAL OF NEUROSCIENCE (2019)
Biased M1 receptor-positive allosteric modulators reveal role of phospholipase D in M1-dependent rodent cortical plasticity
Sean P. Moran et al.
SCIENCE SIGNALING (2019)
Region-specific inhibition of 14-3-3 proteins induces psychomotor behaviors in mice
Kourtney Graham et al.
NPJ SCHIZOPHRENIA (2019)
Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor
E. Scarr et al.
MOLECULAR PSYCHIATRY (2018)
Generation of a whole-brain atlas for the cholinergic system and mesoscopic projectome analysis of basal forebrain cholinergic neurons
Xiangning Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The discovery of VU0486846: steep SAR from a series of M-1 PAMs based on a novel benzomorpholine core
Jeanette L. Bertron et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Synthesis and Pharmacological Evaluation of Heterocyclic Carboxamides: Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor with Weak Agonist Activity and Diverse Modulatory Profiles
Juliana C. C. Dallagnol et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M-1 Muscarinic Acetylcholine Receptors
Emma T. van der Westhuizen et al.
MOLECULAR PHARMACOLOGY (2018)
Biased signalling: from simple switches to allosteric microprocessors
Jeffrey S. Smith et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Lifetime of muscarinic receptor-G-protein complexes determines coupling efficiency and G-protein subtype selectivity
Olga S. Ilyaskina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate
Douglas C. Beshore et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience
J. P. Kesby et al.
TRANSLATIONAL PSYCHIATRY (2018)
Muscarinic M4 Receptors on Cholinergic and Dopamine D1 Receptor-Expressing Neurons Have Opposing Functionality for Positive Reinforcement and Influence Impulsivity
Anna M. Klawonn et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons
Mohammad Golam Sabbir et al.
NEUROPHARMACOLOGY (2018)
cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia
Haitao Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
Sophie J. Bradley et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
Michael R. Wood et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor
Mark S. Moehle et al.
NEURON (2017)
Muscarinic receptor regulates extracellular signal regulated kinase by two modes of arrestin binding
Seung-Ryoung Jung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Discovery of the first low-shift positive allosteric modulators for the muscarinic M1 receptor
Alexander Flohr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping
Madeline F. Long et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery of a novel, CNS penetrant M4 PAM chemotype based on a 6-fluoro-4-(piperidin-1-yl)quinoline-3-carbonitrile core
Blake R. Bewley et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Abnormalities of signal transduction networks in chronic schizophrenia
Jennifer L. McGuire et al.
NPJ SCHIZOPHRENIA (2017)
Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
Marlies V. Hager et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides
James C. Tarr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Challenges in the development of an M4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs
Michael R. Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Developmental specification of forebrain cholinergic neurons
Kathryn C. Allaway et al.
DEVELOPMENTAL BIOLOGY (2017)
4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor
Shailesh N. Mistry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice
Su M. Park et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Changes in BQCA Allosteric Modulation of [3H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations
Brian Dean et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor
Shailesh N. Mistry et al.
ACS CHEMICAL NEUROSCIENCE (2016)
Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition
Michael R. Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Design and optimization of selective azaindole amide M1 positive allosteric modulators
Jennifer E. Davoren et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Further optimization of the M1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration
Joseph D. Panarese et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery and optimization of a novel series of highly CNS penetrant M4 PAMs based on a 5,6-dimethyl-4-(piperidin-1-yl)thieno[2,3-d]pyrimidine core
Michael R. Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
Jennifer E. Davoren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
David M. Thal et al.
NATURE (2016)
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release
Daniel J. Foster et al.
NEURON (2016)
RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining
A. Hadar et al.
TRANSLATIONAL PSYCHIATRY (2016)
G-protein-coupled receptors mediate 14-3-3 signal transduction
Hua Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior
Kwok H. C. Choy et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators
Alice E. Berizzi et al.
MOLECULAR PHARMACOLOGY (2016)
Synthesis and Pharmacological Evaluation of M4 Muscarinic Receptor Positive Allosteric Modulators Derived from VU10004
Tracey Huynh et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Allosteric modulation of nicotinic acetylcholine receptors
Anna Chatzidaki et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Central Cholinergic Neurons Are Rapidly Recruited by Reinforcement Feedback
Balazs Hangya et al.
CELL (2015)
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited
Jordy van Enkhuizen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Regulation of synaptic MAPK/ERK phosphorylation in the rat striatum and medial prefrontal cortex by dopamine and muscarinic acetylcholine receptors
Bing Xue et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2015)
The muscarinic system, cognition and schizophrenia
Sean P. Carruthers et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients
Daniela Hartl et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
Michael Bubser et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators
Scott D. Kuduk et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor
Peter Keov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor
Alaa Abdul-Ridha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Allosteric Modulation of M1 Muscarinic Acetylcholine Receptor Internalization and Subcellular Trafficking
Holly R. Yeatman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Synthesis and Pharmacological Evaluation of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) Designed to Bind Irreversibly to an Allosteric Site of the M1 Muscarinic Acetylcholine Receptor
Briana J. Davie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100
Nellie E. Byun et al.
NEUROPSYCHOPHARMACOLOGY (2014)
International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
Arthur Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2014)
Characterization of the Novel Positive Allosteric Modulator, LY2119620, at the Muscarinic M2 and M4 Receptors
Carrie H. Croy et al.
MOLECULAR PHARMACOLOGY (2014)
Muscarinic Signaling in the Brain
Alexander Thiele
ANNUAL REVIEW OF NEUROSCIENCE, VOL 36 (2013)
Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: Development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia
Uyen Le et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Probing Structural Requirements of Positive Allosteric Modulators of the M4 Muscarinic Receptor
Tracey Huynh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Exploration of Allosteric Agonism Structure-Activity Relationships within an Acetylene Series of Metabotropic Glutamate Receptor 5 (mGlu5) Positive Allosteric Modulators (PAMs): Discovery of 5-((3-Fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254)
Mark Turlington et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis and Pharmacological Profiling of Analogues of Benzyl Quinolone Carboxylic Acid (BQCA) as Allosteric Modulators of the M1 Muscarinic Receptor
Shailesh N. Mistry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
β-Arrestins as Potential Therapeutic Targets for Alzheimer's Disease
Teng Jiang et al.
MOLECULAR NEUROBIOLOGY (2013)
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Andrew C. Kruse et al.
NATURE (2013)
beta-arrestin 2 regulates A beta generation and gamma-secretase activity in Alzheimer's disease
Amantha Thathiah et al.
NATURE MEDICINE (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Emerging paradigms in GPCR allostery: implications for drug discovery
Denise Wootten et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1-42
Helena Janickova et al.
NEUROPHARMACOLOGY (2013)
Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
Alaa Abdul-Ridha et al.
MOLECULAR PHARMACOLOGY (2013)
N-Aryl Piperazine Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Possess Efficacy in Preclinical Models of NMDA Hypofunction and Cognitive Enhancement
K. J. Gregory et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Differential Activation and Modulation of the Glucagon-Like Peptide-1 Receptor by Small Molecule Ligands
Denise Wootten et al.
MOLECULAR PHARMACOLOGY (2013)
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Terry Kenakin et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor
James M. Salovich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Biased signalling and allosteric machines: new vistas and challenges for drug discovery
Terry P. Kenakin
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Discovery of 2-(2-Benzoxazoyl amino)-4-Aryl-5-Cyanopyrimidine as Negative Allosteric Modulators (NAMs) of Metabotropic Glutamate Receptor 5 (mGlu5): From an Artificial Neural Network Virtual Screen to an In Vivo Tool Compound
Ralf Mueller et al.
CHEMMEDCHEM (2012)
Development of Hyperactivity and Anxiety Responses in Dopamine Transporter-Deficient Mice
Alex C. Carpenter et al.
DEVELOPMENTAL NEUROSCIENCE (2012)
Positive and Negative Allosteric Modulators Promote Biased Signaling at the Calcium-Sensing Receptor
Anna E. Davey et al.
ENDOCRINOLOGY (2012)
Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication
Caroline Chambon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation
Meritxell Canals et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Synthesis and Characterization of Novel 2-Amino-3-benzoylthiophene Derivatives as Biased Allosteric Agonists and Modulators of the Adenosine A1 Receptor
Celine Valant et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models
Gregory J. Digby et al.
JOURNAL OF NEUROSCIENCE (2012)
Role of signal transduction crosstalk between adenylyl cyclase and MAP kinase in hippocampus-dependent memory
Zhengui Xia et al.
LEARNING & MEMORY (2012)
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Kazuko Haga et al.
NATURE (2012)
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Marina R. Picciotto et al.
NEURON (2012)
Abnormal Activity of the MAPK- and cAMP-Associated Signaling Pathways in Frontal Cortical Areas in Postmortem Brain in Schizophrenia
Adam J. Funk et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Functional Neuroanatomy of the Basal Ganglia
Jose L. Lanciego et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
M4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition
Hisatsugu Koshimizu et al.
MOLECULAR BRAIN (2012)
The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
Eric R. Kandel
MOLECULAR BRAIN (2012)
Functional significance of M-type potassium channels in nociceptive cutaneous sensory endings
Gayle M. Passmore et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
AKT/GSK3 signaling pathway and schizophrenia
Effat S. Emamian
FRONTIERS IN MOLECULAR NEUROSCIENCE (2012)
Probe Dependence in the Allosteric Modulation of a G Protein-Coupled Receptor: Implications for Detection and Validation of Allosteric Ligand Effects
Celine Valant et al.
MOLECULAR PHARMACOLOGY (2012)
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery
Denise Wootten et al.
MOLECULAR PHARMACOLOGY (2012)
Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease-Like Pathology and Cognitive Decline
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The synthesis and biological evaluation of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes as allosteric modulators of the A1 adenosine receptor
Luigi Aurelio et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Impact of species variability and 'probe-dependence' on the detection and in vivo validation of allosteric modulation at the M4 muscarinic acetylcholine receptor
S. Suratman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Dissecting the Conserved NPxxY Motif of the M-3 Muscarinic Acetylcholine Receptor: Critical Role of Asp-7.49 for Receptor Signaling and Multiprotein Complex Formation
Dasiel O. Borroto-Escuela et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2011)
Discovery of a Selective Allosteric M1 Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold
Scott D. Kuduk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Muscarinic receptor family interacting proteins: Role in receptor function
Dasiel O. Borroto-Escuela et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
The Role of Transmembrane Domain 3 in the Actions of Orthosteric, Allosteric, and Atypical Agonists of the M4 Muscarinic Acetylcholine Receptor
Katie Leach et al.
MOLECULAR PHARMACOLOGY (2011)
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Sudarshan Rajagopal et al.
MOLECULAR PHARMACOLOGY (2011)
The role of G protein-coupled receptors in the pathology of Alzheimer's disease
Amantha Thathiah et al.
NATURE REVIEWS NEUROSCIENCE (2011)
RACK1 is involved in β-amyloid impairment of muscarinic regulation of GABAergic transmission
Wenhua Liu et al.
NEUROBIOLOGY OF AGING (2011)
Differential Effects of Allosteric M1 Muscarinic Acetylcholine Receptor Agonists on Receptor Activation, Arrestin 3 Recruitment, and Receptor Downregulation
Albert A. Davis et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia
Peixiong Yuan et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Structural Determinants of Allosteric Agonism and Modulation at the M4 Muscarinic Acetylcholine Receptor IDENTIFICATION OF LIGAND-SPECIFIC AND GLOBAL ACTIVATION MECHANISMS
Vindhya Nawaratne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway
Eugenie Goupil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effects of Conformational Restriction of 2-Amino-3-benzoylthiophenes on A1 Adenosine Receptor Modulation
Luigi Aurelio et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Deletion of M1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo
Albert A. Davis et al.
JOURNAL OF NEUROSCIENCE (2010)
A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors
Jongrye Jeon et al.
JOURNAL OF NEUROSCIENCE (2010)
Interaction with AKAP79 Modifies the Cellular Pharmacology of PKC
Naoto Hoshi et al.
MOLECULAR CELL (2010)
Phospholipase A2 activity is associated with structural brain changes in schizophrenia
Stefan Smesny et al.
NEUROIMAGE (2010)
Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties
Katie Leach et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Signaling pathways in schizophrenia: emerging targets and therapeutic strategies
Caline S. Karam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M1 Allosteric Muscarinic Receptor Modulators
Scott D. Kuduk et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Structural and functional diversity of native brain neuronal nicotinic receptors
Cecilia Gotti et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence
I. A. Lockhart et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
How Does Arrestin Assemble MAPKs into a Signaling Complex?
Xiufeng Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Allosteric Modulators of the Adenosine A1 Receptor: Synthesis and Pharmacological Evaluation of 4-Substituted 2-Amino-3-benzoylthiophenes
Luigi Aurelio et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
Jana K. Shirey et al.
JOURNAL OF NEUROSCIENCE (2009)
Selectivity of Agonists for the Active State of M-1 to M-4 Muscarinic Receptor Subtypes
Katherine W. Figueroa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
Joy E. Marlo et al.
MOLECULAR PHARMACOLOGY (2009)
Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia
E. Scarr et al.
MOLECULAR PSYCHIATRY (2009)
Altered M1 Muscarinic Acetylcholine Receptor (CHRM1)-Gαq/11 Coupling in a Schizophrenia Endophenotype
Hasib Salah-Uddin et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Regulation and Physiological Functions of G12/13-Mediated Signaling Pathways
Nobuchika Suzuki et al.
NEUROSIGNALS (2009)
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
Lei Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Regulation of amygdalar PKA by β-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning
Yuting Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands
Christopher N Davis et al.
BMC Pharmacology & Toxicology (2009)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction
F. Amenta et al.
CURRENT MEDICINAL CHEMISTRY (2008)
PLC-beta 1 knockout mice as a model of disrupted cortical development and plasticity: Behavioral endophenotypes and dysregulation of RGS4 gene expression
Caitlin E. McOmish et al.
HIPPOCAMPUS (2008)
2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists
Gemma N. Ferguson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
G Protein Coupling and Signaling Pathway Activation by M1 Muscarinic Acetylcholine Receptor Orthosteric and Allosteric Agonists
Rachel L. Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The internalization of the M2 and M4 muscarinic acetylcholine receptors involves distinct subsets of small G-proteins
Cindy Reiner et al.
LIFE SCIENCES (2008)
Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease
Rene O. Sanchez-Mejia et al.
NATURE NEUROSCIENCE (2008)
On the analysis of ligand-directed signaling at G protein-coupled receptors
Frederick J. Ehlert
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Transfection of mutant CREB in the striatum, but not the hippocampus, impairs long-term memory for response learning
Jennifer J. Brightwell et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
W. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phospholipase C-β1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration
C. E. McOmish et al.
MOLECULAR PSYCHIATRY (2008)
Current therapeutic options for Alzheimer's disease
Alberto Lleo
CURRENT GENOMICS (2007)
Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory
Yasushi Satoh et al.
JOURNAL OF NEUROSCIENCE (2007)
Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease
Shirley W. Y. Tsang et al.
NEUROBIOLOGY OF AGING (2007)
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Katie Leach et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Towards a muscarinic hypothesis of schizophrenia
T. J. Raedler et al.
MOLECULAR PSYCHIATRY (2007)
Alternative splicing of RGS8 gene changes the binding property to the M1 muscarinic receptor to confer receptor type-specific Gq regulation
Masayuki Itoh et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice
C Pittenger et al.
JOURNAL OF NEUROSCIENCE (2006)
Activation of muscarinic M4 receptor augments NGF-induced pro-survival Akt signaling in PC12 cells
EH Wu et al.
CELLULAR SIGNALLING (2006)
Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model
A Degroot et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Subtyping schizophrenia: implications for genetic research
A. Jablensky
MOLECULAR PSYCHIATRY (2006)
DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling
JK Millar et al.
SCIENCE (2005)
Allosteric modulation of the cannabinoid CB1 receptor
MR Price et al.
MOLECULAR PHARMACOLOGY (2005)
Roles of phosphorylation-dependent and -independent mechanisms in the regulation of M1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons
JM Willets et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology
RJ Griffin et al.
JOURNAL OF NEUROCHEMISTRY (2005)
An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins
R Mistry et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
ES Emamian et al.
NATURE GENETICS (2004)
RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11α signaling
LS Bernstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor
R Mitchell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions
AA Roy et al.
MOLECULAR PHARMACOLOGY (2003)
Role of protein kinase B in Alzheimer's neurofibrillary pathology
JJ Pei et al.
ACTA NEUROPATHOLOGICA (2003)
M-1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease - Implications in future therapy
A Fisher et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
M1 muscarinic receptor signaling in mouse hippocampus and cortex
AC Porter et al.
BRAIN RESEARCH (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
DJ Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices
JL Berkeley et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2001)
The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons
SE Hamilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rho proteins: Linking signaling with membrane trafficking
AJ Ridley
TRAFFIC (2001)
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia
K Mirnics et al.
MOLECULAR PSYCHIATRY (2001)
The M3 muscarinic acetylcholine receptor expressed in HEK-293 cells signals to phospholipase D via G12 but not Gq-type G proteins -: Regulators of G proteins as tools to dissect pertussis toxin-resistant G proteins in receptor-effector coupling
U Rümenapp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
